← Leaderboards
John Rinehart
Neutherapeutics, Llc
$1,521,271
Attributed
$3,042,541
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2022–23$2M$1.5M$1M$500K$0
'22
'23
Funding mix
By agency
NIH$3,042,541 · 2
By mechanism
R44$2,536,705 · 1
R43$505,836 · 1
Top collaborators
- Roberta Diaz Brinton3 shared
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposLifeDouble-Blind MethodPreventClinical TrialsOpen LabelExhibitsElderlyInnovationPre-ClinicalBrainClinical DevelopmentS Disease Related DementiaS DiseaseAgingCognitive FunctionAgedDrug KineticsFemaleFormulationAssessment ToolAmericanClinical ResearchAlzheimerâS Disease Biomarker
Grant awards (3)
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health$1,199,342
R44 · FY2023 · AG · contact PI
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease$505,836
R43 · FY2023 · AG · contact PI
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health$1,337,363
R44 · FY2022 · AG · contact PI